- Home
- AKRO vs VAC Comparison
AKRO vs VAC Comparison
Compare AKRO & VAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- VAC
- Stock Information
- Founded
- AKRO 2017
- VAC 1984
- Country
- AKRO United States
- VAC United States
- Employees
- AKRO N/A
- VAC N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- VAC Real Estate
- Sector
- AKRO Health Care
- VAC Finance
- Exchange
- AKRO Nasdaq
- VAC Nasdaq
- Market Cap
- AKRO 2.8B
- VAC 2.3B
- IPO Year
- AKRO 2019
- VAC N/A
- Fundamental
- Price
- AKRO $37.63
- VAC $53.18
- Analyst Decision
- AKRO Strong Buy
- VAC Buy
- Analyst Count
- AKRO 9
- VAC 8
- Target Price
- AKRO $76.29
- VAC $97.13
- AVG Volume (30 Days)
- AKRO 1.3M
- VAC 586.5K
- Earning Date
- AKRO 05-09-2025
- VAC 05-07-2025
- Dividend Yield
- AKRO N/A
- VAC 5.94%
- EPS Growth
- AKRO N/A
- VAC N/A
- EPS
- AKRO N/A
- VAC 5.63
- Revenue
- AKRO N/A
- VAC $3,278,000,000.00
- Revenue This Year
- AKRO N/A
- VAC $59.06
- Revenue Next Year
- AKRO N/A
- VAC $3.53
- P/E Ratio
- AKRO N/A
- VAC $9.45
- Revenue Growth
- AKRO N/A
- VAC 3.54
- 52 Week Low
- AKRO $17.86
- VAC $49.22
- 52 Week High
- AKRO $58.40
- VAC $103.51
- Technical
- Relative Strength Index (RSI)
- AKRO 43.61
- VAC 35.65
- Support Level
- AKRO $36.46
- VAC $51.63
- Resistance Level
- AKRO $39.13
- VAC $54.81
- Average True Range (ATR)
- AKRO 3.04
- VAC 4.20
- MACD
- AKRO 0.06
- VAC 0.03
- Stochastic Oscillator
- AKRO 57.38
- VAC 23.84
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About VAC Marriott Vacations Worldwide Corporation
Marriott Vacations Worldwide Corp functions in the United States leisure industry. It owns and manages a cluster of resorts and accommodation facilities under trademarks like Marriott Vacation Club, Grand Residencies, and The Ritz-Carlton Destination Club predominantly in the United States. Some of its properties are also spread across Europe and Asia Pacific. Marriott's majority revenue components include the sale of vacation ownership products such as luxurious vacation packages. In addition, it offers purchase money financing to the end users of its core services. The company operates in two reportable segments: Vacation Ownership and Exchange & Third-Party Management. The majority of revenue is derived from the Vacation Ownership segment.